Michael Klichinsky
Fondatore presso CARISMA THERAPEUTICS, INC.
Patrimonio netto: 736 207 $ in data 30/06/2024
Posizioni attive di Michael Klichinsky
Società | Posizione | Inizio | Fine |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2022 | - |
Fondatore | 01/01/2016 | - | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Direttore Tecnico/Scientifico/R&S | 01/04/2022 | - |
Fondatore | 01/01/2016 | - | |
Corporate Officer/Principal | 01/10/2018 | 01/04/2022 |
Storia della carriera di Michael Klichinsky
Formazione di Michael Klichinsky
University of Pennsylvania | Doctorate Degree |
University of the Sciences in Philadelphia | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Doctorate Degree | 2 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CARISMA THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Michael Klichinsky
- Esperienza